Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer: a Single-arm, Open Clinical Study
Latest Information Update: 30 Jan 2025
Price :
$35 *
At a glance
- Drugs Envafolimab (Primary) ; Fruquintinib
- Indications Adenocarcinoma; Carcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 30 Jan 2025 New trial record